デフォルト表紙
市場調査レポート
商品コード
1405751

うっ血性心不全治療デバイスの市場規模、シェア、動向分析レポート:製品別、地域別、セグメント予測、2023年~2030年

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 105 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
うっ血性心不全治療デバイスの市場規模、シェア、動向分析レポート:製品別、地域別、セグメント予測、2023年~2030年
出版日: 2023年12月01日
発行: Grand View Research
ページ情報: 英文 105 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

うっ血性心不全治療デバイス市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のうっ血性心不全治療デバイス市場規模は、2023年から2030年にかけてCAGR 7.6%を記録し、2030年までに465億8,000万米ドルに達する見込みです。

CVDの負担増は、この分野の有利な成長をもたらす主な要因の1つです。座りがちなライフスタイル、精神的ストレス、ジャンクフード消費傾向は、CVDs発症の主な要因です。

米国のメディケア制度のような好意的な償還政策は、この産業の主要な成長要因であると見られています。各社は現在、患者にとってメリットのある払い戻しが適用される新製品プラットフォームを提供しています。CHFの治療に使用される補助人工心臓(VAD)、植込み型除細動器(ICD)、ペースメーカーなどの機器に償還が適用されます。

業界関係者は、個別化されたケアを提供できる実用性の高い製品を開発することに重点を置いています。これらの進歩は、精度を向上させ、ワークフローを強化し、エラーの発生率を低減するための追加機能を提供しています。

うっ血性心不全治療デバイス市場のレポートハイライト

  • 製品別市場は、補助人工心臓、カウンターパルセーションデバイス、ICD、ペースメーカー、心臓再同期デバイスに区分されます。経静脈型と皮下型の2種類からなるICD分野が2022年に有利なシェアを占め、これにペースメーカー分野が続く。これは、除細動器とペースメーカーが心不全治療の第一線を担っていることに起因しています。
  • 一方、補助人工心臓(VAD)分野は、保険償還の適用範囲と補助人工心臓の技術的進歩により、予測期間中に大きな成長が見込まれています。
  • 補助人工心臓は、移植部位によって左心室補助人工心臓(LVAD)と右心室補助人工心臓(RVAD)に分類されます。LVADとRVADが一緒に移植される場合は、両心室補助装置(BIVAD)と呼ばれます。
  • 北米は2022年の収益シェアで40.55%を超え、市場全体を支配しています。これは、CVDに罹患している人口ベースが大きいことと、高齢者人口ベースが大きいことに起因しています。
  • 市場参入企業は、市場での地位を維持するため、現在の製品ポートフォリオの改善に積極的に取り組んでいます。さらに、医薬品開拓と未開拓国への市場参入が市場成長を促進すると期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 うっ血性心不全治療デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • うっ血性心不全治療デバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 うっ血性心不全治療デバイス市場:製品の推定・動向分析

  • うっ血性心不全治療デバイス市場:重要なポイント
  • うっ血性心不全治療デバイス市場:製品の変動と市場シェア分析、2022年および2030年
  • うっ血性心不全補助装置(VAD)
  • カウンターパルセーションデバイス
  • 植込み型除細動器
  • ペースメーカー
  • 心臓再同期療法

第5章 うっ血性心不全治療デバイス市場:地域の推定・動向分析

  • 地域別の見通し
  • 地域別のうっ血性心不全治療デバイス市場:マーケットプレースにおける重要なポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Jarvik Heart Inc.
    • ReliantHeart, Inc.
    • Biotronik SE & Co. KG
    • Berlin Heart GmbH
    • Abbott (St. Jude Medical)
    • Medtronic
    • Boston Scientific Corporation
    • Teleflex, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait CHF treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 CHF treatment devices: market outlook
  • Fig. 9 CHF treatment devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 CHF treatment devices market driver impact
  • Fig. 15 CHF treatment devices market restraint impact
  • Fig. 16 CHF treatment devices market strategic initiatives analysis
  • Fig. 17 CHF treatment devices market: Product movement analysis
  • Fig. 18 CHF treatment devices market: Product outlook and key takeaways
  • Fig. 19 Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 LVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 RVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BiVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Counter Pulsation Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Implantable Cardioverter Defibrillators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Transvenous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Subcutaneous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Implantable pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 External pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cardiac Resynchronization therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Cardiac Resynchronization Therapy-Defibrillators (CRT-D) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global CHF treatment devices market: Regional movement analysis
  • Fig. 34 Global CHF treatment devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-292-1

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 46.58 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2022, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America dominated the overall market in terms of revenue share at over 40.55% in 2022; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. CHF Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. CHF Treatment Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. CHF Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. CHF Treatment Devices Market: Key Takeaways
  • 4.2. CHF Treatment Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Ventricular Assist Devices (VADs)
    • 4.3.1. Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Counter Pulsation Devices
    • 4.4.1. Counter pulsation devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Implantable Cardioverter Defibrillators
    • 4.5.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pacemakers
    • 4.6.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cardiac Resynchronization Therapy
    • 4.7.1. Cardiac resynchronization therapy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CHF Treatment Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. CHF Treatment Devices Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Jarvik Heart Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. ReliantHeart, Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biotronik SE & Co. KG
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Berlin Heart GmbH
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Abbott (St. Jude Medical)
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Medtronic
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Boston Scientific Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Teleflex, Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives